26 results
S-8 POS
EX-4.5
PYXS
Pyxis Oncology Inc
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
to mean “and/or”; (c) words denoting any gender shall include all genders; (d) the word “hereunder” refers to under this Plan as a whole and not merely
S-8
EX-4.5
PYXS
Pyxis Oncology Inc
23 Aug 23
Registration of securities for employees
5:28pm
to mean “and/or”; (c) words denoting any gender shall include all genders; (d) the word “hereunder” refers to under this Plan as a whole and not merely
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
to each term defined herein shall be equally applicable to both the singular and the plural forms of such term, and words denoting any gender shall
425
8ebeh1sz5c
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
jxorh dna7rwnvkqywbt
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
S-3
EX-1.2
ltdh2wfu
1 Nov 22
Shelf registration
4:51pm
DEF 14A
ckt51kv4u2igzwfh
28 Apr 22
Definitive proxy
4:33pm
10-K
l0opk
29 Mar 22
Annual report
7:36am
424B4
zdtvc
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1
bqs08
17 Sep 21
IPO registration
5:00pm
S-1
EX-10.7
n23qb5c
17 Sep 21
IPO registration
5:00pm
S-1
EX-10.10
7rrd oarfmo4qgidb
17 Sep 21
IPO registration
5:00pm
S-1
EX-10.12
10btfqmyicgkfbp j5w5
17 Sep 21
IPO registration
5:00pm